DK154082C - Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK154082C
DK154082C DK428678A DK428678A DK154082C DK 154082 C DK154082 C DK 154082C DK 428678 A DK428678 A DK 428678A DK 428678 A DK428678 A DK 428678A DK 154082 C DK154082 C DK 154082C
Authority
DK
Denmark
Prior art keywords
homopiperazin
piperazin
dimethoxy
analogue
amino
Prior art date
Application number
DK428678A
Other languages
English (en)
Other versions
DK428678A (da
DK154082B (da
Inventor
Simon Fraser Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to US05/952,317 priority Critical patent/US4188390A/en
Publication of DK428678A publication Critical patent/DK428678A/da
Publication of DK154082B publication Critical patent/DK154082B/da
Application granted granted Critical
Publication of DK154082C publication Critical patent/DK154082C/da
Priority to BG96072A priority patent/BG60337B2/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK428678A 1977-11-05 1978-09-27 Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf DK154082C (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US05/952,317 US4188390A (en) 1977-11-05 1978-10-18 Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
BG96072A BG60337B2 (bg) 1977-11-05 1992-03-16 4-амино-2-(4-)1,4-бензодиоксан-2-карбонил(пиперазин-1-ил или хомопиперазин-1-ил)хиназолини с антихипертензивно действие

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4612877 1977-11-05
GB4612877 1977-11-05

Publications (3)

Publication Number Publication Date
DK428678A DK428678A (da) 1979-05-06
DK154082B DK154082B (da) 1988-10-10
DK154082C true DK154082C (da) 1989-02-27

Family

ID=10439957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK428678A DK154082C (da) 1977-11-05 1978-09-27 Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (36)

Country Link
JP (1) JPS5498792A (da)
AR (2) AR219562A1 (da)
AT (1) AT365186B (da)
AU (1) AU509329B2 (da)
BE (1) BE871771A (da)
CA (1) CA1088059A (da)
CH (1) CH643255A5 (da)
CS (2) CS207671B2 (da)
DD (1) DD139850A5 (da)
DE (1) DE2847623C2 (da)
DK (1) DK154082C (da)
EG (1) EG13594A (da)
ES (2) ES474805A1 (da)
FI (1) FI64366C (da)
FR (1) FR2407929A1 (da)
GR (1) GR81514B (da)
HK (1) HK94284A (da)
HU (1) HU176306B (da)
IE (1) IE47888B1 (da)
IL (1) IL55857A (da)
IN (1) IN148828B (da)
IT (1) IT1100919B (da)
KE (1) KE3350A (da)
LU (2) LU80470A1 (da)
MY (1) MY8500286A (da)
NL (2) NL174549C (da)
NO (1) NO150158C (da)
NZ (1) NZ188813A (da)
PH (1) PH13966A (da)
PL (2) PL119419B1 (da)
PT (1) PT68735A (da)
SE (1) SE437518B (da)
SU (1) SU816403A3 (da)
UA (1) UA8324A1 (da)
YU (2) YU40204B (da)
ZA (1) ZA786184B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002644A1 (en) * 1984-11-01 1986-05-09 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985002617A1 (en) * 1983-12-14 1985-06-20 Takeda Chemical Industries. Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985004658A1 (en) * 1984-04-04 1985-10-24 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepine derivatives and their preparation
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849266B8 (de) * 1996-12-20 2007-10-03 Heumann PCS GmbH Neue polymorphe Form von Doxazosinmesylat (Form III)
TW448155B (en) * 1999-03-29 2001-08-01 Dev Center Biotechnology Method for producing amide compounds and quinazolin derivatives
EP1403263B1 (en) * 2002-09-27 2005-06-22 Council of Scientific and Industrial Research Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
FR2407929B1 (da) 1981-02-27
FI64366C (fi) 1983-11-10
ATA784378A (de) 1981-05-15
IT1100919B (it) 1985-09-28
UA8324A1 (uk) 1996-03-29
EG13594A (en) 1982-03-31
IE47888B1 (en) 1984-07-11
PL210681A1 (da) 1979-11-05
SE7811382L (sv) 1979-05-06
AU509329B2 (en) 1980-05-08
YU255378A (en) 1983-06-30
FI783347A (fi) 1979-05-06
NO783705L (no) 1979-05-08
NL7810909A (nl) 1979-05-08
ES8308559A1 (es) 1980-07-16
IL55857A (en) 1982-07-30
DK428678A (da) 1979-05-06
HK94284A (en) 1984-12-07
ES474805A1 (es) 1980-01-16
DE2847623C2 (de) 1983-06-01
ES480121A0 (es) 1980-07-16
YU38683A (en) 1983-06-30
YU40204B (en) 1985-08-31
HU176306B (en) 1981-01-28
BE871771A (fr) 1979-05-03
NL930062I2 (nl) 1993-11-16
FR2407929A1 (fr) 1979-06-01
CS354491A3 (en) 1992-06-17
AT365186B (de) 1981-12-28
FI64366B (fi) 1983-07-29
NO150158C (no) 1984-08-29
NZ188813A (en) 1980-10-08
NL174549C (nl) 1984-07-02
IL55857A0 (en) 1979-01-31
LU80470A1 (fr) 1980-06-05
PL119419B1 (en) 1981-12-31
IN148828B (da) 1981-06-27
PH13966A (en) 1980-11-12
SE437518B (sv) 1985-03-04
PL119586B1 (en) 1982-01-30
AR223015A1 (es) 1981-07-15
LU88331I2 (fr) 1994-05-04
IE782179L (en) 1979-05-05
GR81514B (da) 1984-12-11
JPS5498792A (en) 1979-08-03
CA1088059A (en) 1980-10-21
PT68735A (en) 1978-12-01
SU816403A3 (ru) 1981-03-23
ZA786184B (en) 1979-10-31
MY8500286A (en) 1985-12-31
JPS5625233B2 (da) 1981-06-11
AR219562A1 (es) 1980-08-29
NL174549B (nl) 1984-02-01
CS207671B2 (en) 1981-08-31
YU40419B (en) 1985-12-31
DD139850A5 (de) 1980-01-23
DK154082B (da) 1988-10-10
IT7829434A0 (it) 1978-11-03
AU4132278A (en) 1979-05-17
NO150158B (no) 1984-05-21
CH643255A5 (en) 1984-05-30
NL930062I1 (nl) 1993-09-01
DE2847623A1 (de) 1979-05-23
KE3350A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
DK159316C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive 4-amino-6,7-dimethoxyquinazolinderivater eller farmaceutisk acceptable syreadditionssalte heraf
DK152430C (da) Analogifremgangsmaade til fremstilling af heterocyclisk substituerede 4-amino-6,7-dimethoxy-2-piperazinoquinazolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK337383D0 (da) Fremgangsmade til fremstilling af 4-amino-6,7-dimethoxyquinolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK149022C (da) Analogifremgangsmaade til fremstilling af aminderivater af di-o-(n-alkyl- eller alkenyl)-glyceroler eller farmaceutisk acceptable syreadditionssalte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK151331C (da) Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK160045C (da) Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
DK154082C (da) Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK140695B (da) Analogifremgangsmaade til fremstilling af 2,4-diamo-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK152208C (da) Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK146540C (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen, eller syreadditionssalte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK152211C (da) Analogifremgangsmaade til fremstilling af n-phenyl-n-(4-piperidinyl)-amider eller farmaceutisk acceptable syreadditionssalte deraf.
DK317678A (da) Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera
DK160874C (da) Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148683C (da) Analogifremgangsmaade til fremstilling af pyridazinylhydrazinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149889C (da) Analogifremgangsmaade til fremstilling af dibenzo(d,g)(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
DK149750C (da) Analogifremgangsmaade til fremstilling af n-alkenylmoranolin-derivater eller farmaceutiske acceptable syreadditionssalte deraf
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf